| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |